Answers are grounded in this paper and cite their sources.
Monoclonal antibodies targeting the CGRP pathway are recommended for migraine prevention as they are effective and safe also in the long-term.
No takes yet. Share an insight, caveat, or question.
Sacco et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: